Tue, February 28, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
ICON Acquires PriceSpective
Mon, February 27, 2012
Sat, February 25, 2012
Fri, February 24, 2012
[ Fri, Feb 24th 2012 ] - Market Wire
BrainStorm Featured on CNBC
Thu, February 23, 2012
[ Thu, Feb 23rd 2012 ] - Market Wire
00 am ET
Wed, February 22, 2012
Tue, February 21, 2012
Mon, February 20, 2012
Sat, February 18, 2012
Fri, February 17, 2012
Thu, February 16, 2012
Wed, February 15, 2012
[ Wed, Feb 15th 2012 ] - Market Wire
Biogen Idec adquiere Stromedix
Tue, February 14, 2012

Idenix Pharmaceuticals to Present at the Citi Global Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. nt-at-the-citi-global-healthcare-conference.html
Published in Health and Fitness on Tuesday, February 21st 2012 at 13:16 GMT by Market Wire   Print publication without navigation


Idenix Pharmaceuticals to Present at the Citi Global Healthcare Conference -- CAMBRIDGE, Mass., Feb. 21, 2012 /PRNewswire/ --

Idenix Pharmaceuticals to Present at the Citi Global Healthcare Conference

[ ]

CAMBRIDGE, Mass., Feb. 21, 2012 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: [ IDIX ]) announced today that Idenix management will present a corporate overview at the Citi Global Healthcare Conference on February 27, 2012 at 3:00 p.m. ET at the Waldorf Astoria in New York City.  

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at [ www.idenix.com ]. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.

About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to [ http://www.idenix.com ].

Idenix Pharmaceuticals Contacts:
Kelly Barry (617) 995-9033 (media)
Teri Dahlman (617) 995-9807 (investors

SOURCE Idenix Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.idenix.com ]


Publication Contributing Sources